After Hours Gainer
ARTV Artiva Biotherapeutics2.77-0.24-8.0%
After Hours:6.16+3.39 (+122.4%)
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
Globe NewswireThu, 16-Oct 4:05 PM
After Hours:5.91+3.14 (+113.4%)
